More
    Guided Solutions - Connecting Talent With Innovation/div>

    Neurovalens receives FDA approval for weight management device

    Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for weight management. The medical device firm's Modius technology uses low-level electrical...

    Neurovalens receives FDA approval for weight management device

    Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for...

    FDA clears HeartBeam’s at-home arrhythmia assessment tool

    HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for...

    Impulse Dynamics raises $158M for heart failure treatment

    Impulse Dynamics announced that it raised more than $158 million in financing to support its heart failure treatment technology. New institutional investors, including Sands Capital...

    Saluda Medical raises $150M in Australian IPO to support neuromod tech

    Saluda Medical announced that it raised $150 million through an initial public offering on the Australian Securities Exchange (ASX). Minneapolis-based Saluda raised A$230.8 million through...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    JenaValve reports positive Trilogy heart valve data for aortic regurgitation

    JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system. Results from the ALIGN-AR pivotal...

    Vexev robotic ultrasound study meets endpoints

    Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...

    Hyperion completes first-in-human study of Ivy robotic vascular access platform

    Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform. Ivy integrates advanced imaging, AI and robotic...

    AtriCure treats first patient in the BoxX-NoAF clinical trial

    AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

    Innovation

    Regulatory Approvals

    Neurovalens receives FDA approval for weight management device

    Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for...

    FDA clears HeartBeam’s at-home arrhythmia assessment tool

    HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for...

    Impulse Dynamics raises $158M for heart failure treatment

    Impulse Dynamics announced that it raised more than $158 million in financing to support its heart failure treatment technology. New institutional investors, including Sands Capital...

    Saluda Medical raises $150M in Australian IPO to support neuromod tech

    Saluda Medical announced that it raised $150 million through an initial public offering on the Australian Securities Exchange (ASX). Minneapolis-based Saluda raised A$230.8 million through...

    M&A

    Archives

    Latest articles